Go Slow With Pharma IPOs: KYTHERA, Intercept
Francis Gaskins, president of IPO Desktop, says he's going to sit on the sidelines with KYTHERA and Intercept.
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.
